p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

606 indexed citations
published 2011

Countries where authors are citing p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

Specialization
Citations

This map shows the geographic impact of p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs more than expected).

Fields of papers citing p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs.

About p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

This paper, published in 2011, received 606 indexed citations . Written by Chun-Ju Chang, Chi-Hong Chao, Weiya Xia, Jer-Yen Yang, Yan Xiong, Chia‐Wei Li, Wen-Hsuan Yu, Sumaiyah K. Rehman, Jennifer L. Hsu and Heng‐Huan Lee covering the research area of Oncology, Pulmonary and Respiratory Medicine and Cancer Research. It is primarily cited by scholars working on Molecular Biology (441 citations), Cancer Research (326 citations) and Oncology (320 citations). Published in Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/ncb2173.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026